This month, many places will implement the results of the seventh batch of national procurement, Henan, Qinghai, Zhejiang... Timeline at a glance

【Pharmaceutical Network Industry News】The seventh batch of centralized procurement of drugs in the country has attracted much attention, involving drugs for common and chronic diseases such as hypertension, diabetes, and anti-infection, as well as drugs for major diseases such as lung cancer, liver cancer, kidney cancer, and bowel cancer, and the average price of the selected drugs has been reduced by 48%.

From November 1, 2022, the seventh batch of national centralized procurement will enter the formal implementation stage, and many provinces in China have issued relevant notices to clarify the implementation time and specific requirements
of the seventh batch of national procurement.
The author has briefly sorted out
the timetable of each place.
Henan: Implementation of the selection results from November 1 From November 1, Henan began to implement the seventh batch of national centralized procurement drug prices, and required that the purchase agreement be signed once a year during the procurement cycle, and when the purchase agreement is renewed, the agreed purchase volume of the selected products is in principle not less than the agreed purchase volume
of the previous year 。 Qinghai: Implementation of the selection results from November 1 Like the implementation time of Henan Province, Qinghai will also implement the seventh batch of national centralized procurement drug prices from November 1, and at the same time require the purchase agreement to be signed once a year during the procurement cycle, and when the purchase agreement is renewed, the agreed purchase volume of the selected products is in principle not less than the agreed purchase volume
of the previous year.
Tianjin: Implementation of the selection results from November 7 Tianjin Municipality has made it clear that the selection results will be implemented on November 7, and requires the unselected varieties to be implemented on schedule according to the gradient price reduction results, the purchase agreement is signed once a year during the procurement cycle, and the uncontinued varieties after the expiration of the procurement cycle continue to be implemented
according to the market plan.
Zhejiang: Implementation of the selection results from November 10 From November 10, Zhejiang will implement the selection results and clearly implement the procurement cycle uniformly determined by the National Centralized Drug Procurement Document (GY-YD2022-1), and the purchase agreement will be signed
once a year.
Gansu: Implement the selection results from November 15 From November 15, the whole province of Gansu will implement the selection results, and clarify that, in principle, medical institutions should complete the signing of the purchase agreement by November 10, and the selected enterprises should urge the distribution companies to jointly complete the signing
of the agreement by November 15.
Shandong: Selection results will be implemented from November 18 Shandong Province will implement the selection results
from November 18.
Shandong Province clarified that before November 13, the main supplier enterprises and backup supply enterprises will respectively hang the selected drugs and spare drugs on the provincial centralized procurement platform for drugs and equipment according to the selected price, so that medical institutions can purchase an appropriate amount of selected drugs for stock
.
Guizhou: Implementation of the selection results from November 18 Guizhou Province clarified that the selection results will be implemented from November 18, 2022, requiring the selected and alternative manufacturers to log in to the official system to confirm the data of the drug hanging network and build the distribution relationship, so as to ensure that medical institutions can place orders and purchases
normally in the system from November 18.
Liaoning: Implementation of the selection results from November 20 Liaoning Province will implement the selection results from November 20, requiring all relevant drug production and distribution enterprises and medical and health institutions to strengthen daily communication and ensure that goods are prepared to relevant medical and health institutions
in advance by November 19 。 Shanxi: Implementation of the selection results from November 20 Shanxi Province has implemented the selection results since November 20, 2022, and the province requires that the provincial centralized bidding and procurement center of drugs and devices will promptly organize the selected products of Shanxi Province to be listed on the provincial centralized procurement platform for drugs and devices, and organize the selected production enterprises, distribution enterprises and medical institutions to complete the signing
of the "tripartite agreement" contract for volume procurement in accordance with the requirements of relevant documents.
Guangdong: Selection results will be implemented from November 30 Guangdong Province has made it clear that the results of the selection will be implemented from November 30
.
According to the provisions of the "National Centralized Drug Procurement Document" (GY-YD2022-1) issued by the National Joint Procurement Office, the seventh batch of national procurement increases the backup supply mechanism, and all relevant procurement platforms should urge the selected enterprises to be listed on the platform in a timely manner according to the supply list, and the alternative enterprises should be listed on the network
according to their spare supply prices.
In addition to the above-mentioned provinces and cities, there are also some provinces and cities that are expected to implement the results in late November, such as Ningxia (as early as November 20, but no later than November 30), Anhui, Jilin, Hubei (mid-to-late November), Shanghai (late November), Jiangsu, Hainan (late November), etc
.
At present, the seventh round of drug centralized procurement has been carried out, and the eighth round is also like an arrow, under the normalization of centralized procurement, drug price reduction has become a trend, reducing the burden of drug costs for patients, but also forcing pharmaceutical companies to transform
in the direction of innovation.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice
to anyone.